Novamex USA Ltd. is pleased to announce that it has retained the Montreal based firm of VetConsul Inc. to complete a commercialized version of its test to detect BSE, "Mad Dow Disease". VetConsul Inc., whose expertise is concentrated in the area of rapid test development, is headed by Dr. M. Achacha, DVM, M.Sc., who holds a Ph.D. in Veterinary Microbiology and Immunology from the University of Montreal. The VetConsul team will be completing the development of a Rapid Diagnostic Pre Mortem "BSE CHECK test" which will be performed directly on serological samples. This state-of-the-art technology will yield rapid results without the need to first slaughter the animal. The Novamex "BSE CHECK test" will use an antigen-monoclonal antibody reaction. After completing the commercialized "BSE CHECK test", Novamex will work with regulatory bodies in both Canada and the USA, to register the product for distribution, which is expected to take place later this year. Novamex USA Ltd. is a publicly traded company, currently listed on the Pink Sheets under the symbol NOVM.